BAYER AG
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Non-proliferative Diabetic Retinopathy Treated With Runcaciguat
- Conditions
- Interventions
- First Posted Date
- 2021-01-25
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 109
- Registration Number
- NCT04722991
- Locations
- 🇺🇸
Austin Retina Associates - Central, Austin, Texas, United States
🇩🇰Aarhus Universitetshospital, Aarhus N, Denmark
🇺🇸Retinal Consultants Medical Group, Inc, Modesto, California, United States
A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants
- Conditions
- Interventions
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Bayer
- Target Recruit Count
- 30
- Registration Number
- NCT04720092
- Locations
- 🇩🇪
CRS Clinical-Research-Services Mönchengladbach GmbH, Mönchengladbach, Nordrhein-Westfalen, Germany
A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 93
- Registration Number
- NCT04713826
- Locations
- 🇩🇪
Ruhrlandklinik, Westdeutsches Lungenzentrum, Essen, Nordrhein-Westfalen, Germany
🇩🇪Advanced Sleep Research GmbH, Berlin, Germany
🇨🇭UniversitätsSpital Zürich, Zürich, Switzerland
A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 175
- Registration Number
- NCT04704154
- Locations
- 🇨🇳
Chi Mei Medical Center, Taikang, Tainan, Taiwan
🇬🇧Royal Marsden NHS Trust (Surrey), Sutton, Surrey, United Kingdom
🇺🇸City of Hope National Medical Center, Duarte, California, United States
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
- Conditions
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 95
- Registration Number
- NCT04696055
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇩🇪Eberhard-Karls-Universität Tübingen, Tübingen, Baden-Württemberg, Germany
🇫🇷Hôpital de la Croix Rousse, Lyon, France
A Study to Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its Safety
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 103
- Registration Number
- NCT04681144
- Locations
- 🇨🇴
Many Locations, Multiple Locations, Colombia
A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)
- Conditions
- Interventions
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2000
- Registration Number
- NCT04665570
- Locations
- 🇮🇳
Many locations, Multiple Locations, India
A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.
- Conditions
- Interventions
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Bayer
- Registration Number
- NCT04661917
- Locations
- 🇫🇮
Päijät-Hämeen keskussairaala, Lahti, Finland
🇦🇹Landeskrankenhaus Feldkirch, Feldkirch, Vorarlberg, Austria
🇦🇹Zentrum f. klinische Studien Dr. Hanusch GmbH, Wien, Austria
Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 6
- Registration Number
- NCT04654897
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico
- First Posted Date
- 2020-11-27
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 153
- Registration Number
- NCT04645979
- Locations
- 🇲🇽
Many locations, Multiple Locations, Mexico